Market Research Logo

The Emerging Cancer Vaccine Market, 2nd Edition

Propelled by advances in molecular biology, the cancer vaccine industry is poised for unprecedented growth. This second edition of Kalorama’s groundbreaking 2003 study completely updates the market data and reviews the technological, clinical, and business trends that have shaped and reshaped this emerging field.

Specific segments covered in the report include:

  • Cervical cancer,
  • Colorectal cancer,
  • Lung cancer,
  • Lymphoma,
  • Melanoma,
  • Prostate cancer, and
  • Other cancers for which vaccines are in development.

Each market segment provides an overview, descriptions of products available and in development, market estimates and forecasts for 2007-2012 by product, and competitive analysis of leading developers, including forecasted market share for 2012. The report also includes statistical information on cancers by type worldwide and in the United States. Profiles of the following developers and marketers are also included:

  • Advaxis, Inc.
  • Antigenics, Inc.
  • Aphton Corporation
  • AVAX Technologies, Inc.
  • Biomira, Inc.
  • Biovest International, Inc.
  • Cell Genesys, Inc.
  • Dendreon Corporation
  • Favrille, Inc.
  • GenMax Corporation
  • Genitope Corporation
  • Genzyme
  • Geron Corporation
  • GlaxoSmithKline
  • IDM
  • Intracel
  • Large Scale Biology Corporation
  • Medarex, Inc.
  • MedImmune, Inc.
  • Merck & Company, Inc.
  • Northwest Biotherapeutics
  • Oxford Biomedica, Plc
  • Pharmexa Group
  • Progenics Pharmaceuticals, Inc.
  • Therion Biologics Corporation
  • Vical, Inc.
  • YM Biosciences, Inc.

The information for this report was gathered using both primary and secondary research including comprehensive research of secondary sources such as company literature, databases, investment reports, and medical and business journals. Telephone interviews and email correspondence were the primary method of gathering information. Kalorama Information conducted interviews with dozens of key industry officials, consultants, health care providers, and government personnel. These sources were the primary basis in gathering information specifically relating to revenue and market share data presented in this report. Specific interviews with pharmaceutical company representatives included marketing directors, division managers, and development representatives.


  • Executive Summary
    • INTRODUCTION
    • SCOPE AND METHODOLOGY
    • SIZE AND GROWTH OF THE MARKET
    • ISSUES AND TRENDS AFFECTING MARKET
    • COMPETITIVE ANALYSIS
    • PROFILES
  • Introduction
    • HISTORY AND GROWTH OF THE CANCER TREATMENT MARKET
    • TYPES OF VACCINES
      • Antigen/Adjuvant Vaccines
      • Whole Cell Tumor Vaccines
      • Dendritic Cell (DC) Vaccines
      • Viral Vectors and DNA Vaccines
      • Idiotype Vaccines
      • Types of Therapeutic Vaccines
    • INDUSTRY STRUCTURE
    • DEMOGRAPHICS AND STATISTICS
      • Table Estimated and Projected World Cancer Incidence by Selected Types of Cancer, 2005 and 2020 Cancer Incidence (in thousands)
      • Table Estimated and Projected World Cancer Mortality by Selected Types of Cancer, 2005 and 2020
      • Table Total Cancer Incidence by Sex and Country, 2006 Estimates
      • Table Estimated Cancer Incidence by World Region and Type of Cancer Cancer Incidence by World Region (in thousands)
      • Table World Population by Selected Geographical Region, 2006-2050
      • Table Estimated World Population by Age and Geographical Region, 2006
      • Table Life Expectancy at Birth by Selected Countries, Projected 2006
      • Table United States Life Expectancy at Birth, 1990 and 2000; Projections, 2006 and 2010
      • Table United States Average Years of Life Lost Per Person Dying of Cancer, All Races, Both Sexes, 2002
  • Cervical Cancer Vaccines
    • OVERVIEW
      • Table Estimated U.S. and World Incidence and Mortality of Cervical Cancer
    • VACCINES PRODUCTS
      • On the Market
      • In Development
        • Table Cervical Cancer Vaccines in the Pipeline (Product, Developer, Phase, Earliest Approval Date)
    • MARKET AND PRODUCT LAUNCH FORECASTS
      • Table The World Market for Cervical Cancer Vaccines Revenues and Growth Rate 2007-2012
      • Table The Projected Cervical Cancer Vaccine Market in Comparison to Traditional Therapeutics, 2012
    • POTENTIAL COMPETITORS AND ANALYSIS, 2012
      • Table The Cervical Cancer Vaccine Market Projected Revenues and Market Share by Leading Supplier 2012
  • Colon/Rectal Cancer Vaccines
    • OVERVIEW
      • Table Estimated U.S. and World Incidence and Mortality of Colon/Rectal Cancer
    • VACCINE PRODUCTS
      • On the Market
      • In Development
        • Table Colon/Rectal Cancer Vaccines in the Pipeline (Product, Developer, Phase, Earliest Approval Date)
    • MARKET AND PRODUCT LAUNCH FORECASTS
      • Table The World Market for Colon/Rectal Cancer Vaccines Revenues and Growth Rate 2007-2012
      • Table The Colon/Rectal Cancer Vaccine Market in Comparison to Traditional Therapies, 2012
    • POTENTIAL COMPETITORS AND ANALYSIS, 2012
      • Table The Colon/Rectal Cancer Vaccine Market Projected Revenues and Market Share by Leading Supplier 2012
  • Lung Cancer Vaccines
    • OVERVIEW
      • Table Types of Primary Lung Cancer, Risk Factors, Percent of Cases
      • Table Cancer Vaccines: Estimated World Incidence and Mortality of Lung Cancer (thousands)
    • VACCINE PRODUCTS IN DEVELOPMENT
      • Stimuvax
      • ICN-101
      • GV-1001
      • Ep2101
      • Oncophage
      • PanVac + Taxotere
      • MAGE-3 Peptide
      • INGN 225
      • TG 4010
      • L-VAX
      • ALT-110
      • CEA-TriCom
      • DC Vax
      • Lapuleucel-T
      • L523S
        • Table Lung Cancer Vaccines in the Pipeline (Product, Developer, Phase, Earliest Approval Date)
    • MARKET AND PRODUCT LAUNCH FORECASTS
      • Table The World Market for Lung Cancer Vaccines Revenues and Growth Rate 2007-2012
      • Table The Lung Cancer Vaccine Market in Comparison to Traditional Therapies, 2012
    • POTENTIAL COMPETITORS AND ANALYSIS, 2012
      • Table The Lung Cancer Vaccine Market Projected Revenues and Market Share by Leading Supplier 2012
  • Lymphoma Vaccines
    • OVERVIEW
      • Table Classification of Non-Hodgkin's Lymphomas
      • Table Estimated U.S. and World Incidence and Mortality of Lymphoma
    • VACCINES IN DEVELOPMENT
      • MyVax
      • BiovaxID
      • FavId
      • Oncophage
      • TG4010
      • FAV-201
      • Non-Hodgkin's Lymphoma Vaccine
      • BGLP40 Vaccine
        • Table Lymphoma Vaccines in the Pipeline (Product, Developer, Phase, Earliest Approval Date)
    • MARKET AND PRODUCT LAUNCH FORECASTS
      • Table The World Market for Lymphoma Vaccines Revenues and Growth Rate 2007-2012
      • Table The Lymphoma Vaccine Market in Comparison to Traditional Therapies, 2012
    • POTENTIAL COMPETITORS AND ANALYSIS, 2012
      • Table The Lymphoma Vaccine Market Projected Revenues and Market Share by Leading Supplier 2012
  • Melanoma Vaccines
    • OVERVIEW
      • Table Malignant Conditions of the Skin
      • Table Estimated U.S. and World Incidence and Mortality of Melanoma
    • VACCINES ON THE MARKET
    • VACCINES IN DEVELOPMENT
      • M-VAX
      • GMK
      • Allovectin-7
      • MDX-010/MDX-1379
      • Oncophage
      • Canvaxin
      • Melacine
      • Triple Peptide Vaccine
      • MART-1/Melan-A
      • MAGE-3 Peptide
      • TriCom
      • Tyrosinase Peptide
      • Uvidem
      • Melan-A/MART-1 and gp100
      • ALVAC -CEA/B7.1
      • MDX-1106/ONO-4538
    • MARKET AND PRODUCT LAUNCH FORECASTS
      • Table Melanoma Vaccines in the Pipeline (Product, Developer, Phase, Earliest Approval Date)
      • Table The World Market for Melanoma Vaccines Revenues and Growth Rate 2007-2012
      • Table The Melanoma Vaccine Market in Comparison to Traditional Therapies, 2012
    • POTENTIAL COMPETITORS AND ANALYSIS, 2012
      • Table The Melanoma Vaccine Market Projected Revenues and Market Share by Leading Supplier 2012
  • Prostate Cancer Vaccines
    • OVERVIEW
      • Table Estimated U.S and World Incidence and Mortality of Prostate Cancer
    • VACCINES IN DEVELOPMENT
      • Provenge
      • DC Vax-Prostate
      • GVAX
      • Stimuvax
      • GnRH Pharmaccine Therapeutic Vaccine
      • IGN-101
      • Pentrix
      • PROSTVAC-VF
      • Telomerase Cancer Vaccine
      • TG4010
      • Norelin
      • PSMA RS Protein Vaccine
      • Luteinizing Hormone Releasing Hormone
      • ALT-110
        • Table Prostate Cancer Vaccines in the Pipeline (Product, Developer, Phase, Earliest Approval Date)
    • MARKET AND PRODUCT LAUNCH FORECASTS
      • Table The World Market for Prostate Cancer Vaccines Revenues and Growth Rate 2007-2012
      • Table The Prostate Cancer Vaccine Market in Comparison to Traditional Therapies, 2012
    • POTENTIAL COMPETITORS AND ANALYSIS, 2012
      • Table The Prostate Cancer Vaccine Market Projected Revenues and Market Share by Leading Supplier 2012
  • Various Cancer Vaccines
    • OVERVIEW
      • Bladder Cancer
      • Breast Cancer
      • Stomach Cancer
      • Liver Cancer
      • Pancreatic Cancer
      • Kidney Cancer
      • Leukemia
        • Table Types of Leukemia (Incidence, Age of Onset, Clinical Manifestations)
      • Multiple Myeloma
      • Neuroblastoma
      • Ovarian Cancer
      • Sarcoma
        • Table Estimated U.S. World Incidence and Mortality of Various Cancers (Bladder, Breast, Kidney, Leukemia, Liver, Neuroblastoma, Ovarian, Pancreatic, Stomach)
    • VACCINES ON THE MARKET
      • BCG Therapy (OncoTICE-Organon Teknika; Immucyst-Sanofi Pasteur; Pacis-Shire Pharmaceuticals)
    • VACCINES IN DEVELOPMENT
      • Oncophage
      • Insegia
      • Avicine
      • MyVax
      • PANVAC-VF
      • Theratope
      • Bexidem
      • AG-858
      • DC Vax
      • GVAX
      • IGN-101
      • O-VAX Autologous Cell Vaccine
      • PX 104.1
      • TroVAX
      • Dendritic Cell/Tumor Cell Fusion Cancer Vaccine
      • INGN 225
      • ALT-110
      • DNA Cancer Vaccine
      • GV 1001
      • Lapuleucel-T
      • Lovaxin C
      • MDX-1307
      • Telomerase
        • Table Various Cancer Vaccines in the Pipeline (Product, Developer, Phase, Cancer Type, Earliest Approval Date)
    • MARKET AND PRODUCT LAUNCH FORECASTS
      • Table The World Market for Other Cancer Vaccines Revenues and Growth Rate 2007-2012
      • Table Figure 9-3 The Emerging Various Cancer Vaccine Market in Comparison to Traditional Therapies, 2012
    • POTENTIAL COMPETITORS AND ANALYSIS, 2012
      • Table Projected Revenues and Market Share of Leading Suppliers of Other Cancer Vaccines 2012
  • Issues and Trends
    • EARLY DETECTION AND SCREENING
      • Table Cancer Detection Tests
    • MONOCLONAL ANTIBODIES AND THERAPEUTIC VACCINES
    • POLITICAL AND SOCIAL PRESSURE
    • INSURANCE AND REIMBURSEMENT ISSUES
    • PERSONALIZED MEDICINE
    • PHARMACOGENOMICS
    • VACCINE STRATEGIES
    • NEW GENETIC TECHNIQUE
    • FUTURE GROWTH IN VACCINES
  • Total Market Forecasts
    • OVERVIEW
    • TOTAL MARKET SIZE AND FORECAST
      • Table Cancer Vaccines Market by Cancer Type, 2007-2012
      • Table Share of the Cancer Vaccine by Vaccine Indication, 2012
    • COMPETITOR ANALYSIS
      • Table Suppliers/Developers of Vaccines by Cancer Type and Development Phase
      • Table Cancer Vaccine Trials, Distribution by Cancer Type, 2006
      • Table Cancer Vaccines: Cancer Vaccines in Development by Type and Phase
      • Table Cancer Vaccines: Cancer Vaccines in Developments by Phase, 2006
    • MARKET ANALYSIS
  • Corporate Profiles
    • INTRODUCTION
    • ADVAXIS, INC.
    • ANTIGENICS, INC.
    • APHTON CORPORATION
    • AVAX TECHNOLOGIES, INC.
    • BIOMIRA, INC.
    • BIOVEST INTERNATIONAL, INC.
    • CELL GENESYS, INC.
    • DENDREON CORPORATION
    • FAVRILLE, INC.
    • GENEMAX CORPORATION
    • GENITOPE CORPORATION
    • GENZYME MOLECULAR ONCOLOGY
    • GERON CORPORATION
    • GLAXOSMITHKLINE PLC
    • IDM PHARMA, INC.
    • INTRACEL RESOURCES LLC
    • LARGE SCALE BIOLOGY CORPORATION
      • MEDAREX, INC.
      • MEDIMMUNE, INC.
      • MERCK & COMPANY, INC.
      • NORTHWEST BIOTHERAPEUTICS, INC.
      • OXFORD BIOMEDICA PLC
      • PHARMEXA GROUP
    • PROGENICS PHARMACEUTICALS, INC.
    • THERION BIOLOGICS CORPORATION
    • VICAL, INC.
    • YM BIOSCIENCES, INC.
  • Company Directory

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report